LATE-BREAKING CLINICAL TRIALS

Moderator(s)

• 

  Joshua Beckman, MD

  Chief, Division of Vascular Medicine
  UT Southwestern Medical Center
  Vascular Medicine
  Dallas, Texas, United States

  Disclosure(s): Janacare: Stockholder - Privately-held company
  Medtronic: Consultant
  Merck: Consultant
  Novartis: Consultant
  Novo Nordisk: Consultant
  Regeneron: Consultant
  tourmaline: Consultant

Panel(s)

• 

  Ehrin Armstrong, MD

  Interventional Cardiology and Vascular Intervention
  Swedish Medical Center
  Interventional Cardiology
  Denver, Colorado, United States

  Disclosure(s): No financial relationships to disclose
• 

  Bryan Fisher, MD

  Vascular Surgeon
  The Surgical Alliance
  Vascular Surgery
  Hendersonville, Tennessee, United States

  Disclosure information pending.
• 

  Minhaj Khaja, MD, MBA

  Professor of Radiology and Cardiac Surgery
  University of Michigan Health
  Interventional Radiology
  Ann Arbor, Michigan, United States

  Disclosure(s): Boston Scientific: Advisory Board; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Medtronic: Advisory Board; Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
• 

  Prakash Krishnan, MD

  Director of Endovascular Services
  Mount Sinai
  Interventional Cardiology
  New York, New York, United States

  Disclosure(s): No financial relationships to disclose
• 

  Jason Lee, MD

  Division Chief, Vascular Surgery
  Stanford University Medical Center
  Vascular Surgery
  Palo Alto, California, United States

  Disclosure(s): No financial relationships to disclose
• 

  Elina Quiroga, MD, MPH

  Professor
  University of Washington
  Vascular Surgery
  Seattle, Washington, United States

  Disclosure(s): WL Gore: Consultant

Presentations:

• 4:45pm - 4:55pm PT

  Prospective, Multicenter Evaluation of Transcarotid Artery Revascularization (TCAR) In Standard-Risk Patients: 1-Year Outcomes of the ROADSTER 3 Study
  

  Speaker: Meghan Dermody, MD – Penn Medicine Lancaster General Hospital
• 4:55pm - 5:00pm PT

  Panel Discussion
• 5:00pm - 5:10pm PT

  Potential for Sustained Abdominal Aortic Aneurysm Growth Stabilization After a Single Intra-Aortic Administration of Pentagalloylglucose: Clinical Evidence From a Phase I Study With the Nectero EAST® System
  

  Speaker: Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed – Prince of Wales Hospital
• 5:10pm - 5:15pm PT

  Panel Discussion
• 5:15pm - 5:25pm PT

  AGILITY: A Prospective, Multi-Center Evaluation of the BD Low Profile Vascular Covered Stent (Revello) in Peripheral Artery Disease
  

  Speaker: Sean P. Lyden, MD – Cleveland Clinic
• 5:25pm - 5:30pm PT

  Panel Discussion